This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
News|Articles|September 15, 2022
Leistritz to Host Twin Extrusion Workshop
Author(s)Pharmaceutical Technology Editors
Leistritz’s Twin Extrusion Workshop, hosted from Nov. 29 to Dec. 1 in Warren, NJ, will dovetail classroom training and twin screw demonstrations.
Advertisement
Leistritz recently announced the date and location for its Twin Extrusion Workshop, which will be held from Nov. 29 to Dec. 1 at the Hilton Somerset Hill Hotel in Warren, NJ. Classroom training will be dovetailed with twin screw demonstrations at the Leistritz Process Laboratory in Branchburg, NJ.
The first day of the workshop will focus on classroom theory and will feature live twin screw extrusion system demonstrations. The second will touch on concepts like rheology and die design basics, featuring interactive screw programming demonstrations. The last day is optional and dedicated to various pharmaceutical and life science applications such as granulation, nano-scale sampling, and downstream technologies.
Source: Leistritz
Advertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement